nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Pollakiuria—Temozolomide—skin cancer	0.00209	0.0021	CcSEcCtD
Naratriptan—Skin disorder—Imiquimod—skin cancer	0.00208	0.0021	CcSEcCtD
Naratriptan—Hyperhidrosis—Imiquimod—skin cancer	0.00207	0.00209	CcSEcCtD
Naratriptan—Photosensitivity reaction—Temozolomide—skin cancer	0.00206	0.00208	CcSEcCtD
Naratriptan—Hyperglycaemia—Temozolomide—skin cancer	0.00204	0.00205	CcSEcCtD
Naratriptan—Angina pectoris—Fluorouracil—skin cancer	0.00203	0.00204	CcSEcCtD
Naratriptan—Pneumonia—Temozolomide—skin cancer	0.00202	0.00204	CcSEcCtD
Naratriptan—Depression—Temozolomide—skin cancer	0.00201	0.00202	CcSEcCtD
Naratriptan—Body temperature increased—Vemurafenib—skin cancer	0.00199	0.002	CcSEcCtD
Naratriptan—Neuropathy peripheral—Temozolomide—skin cancer	0.00197	0.00199	CcSEcCtD
Naratriptan—Swelling—Docetaxel—skin cancer	0.00197	0.00198	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00195	0.00197	CcSEcCtD
Naratriptan—Paraesthesia—Imiquimod—skin cancer	0.00192	0.00194	CcSEcCtD
Naratriptan—Chills—Bleomycin—skin cancer	0.00192	0.00194	CcSEcCtD
Naratriptan—Dyspnoea—Imiquimod—skin cancer	0.00191	0.00193	CcSEcCtD
Naratriptan—Somnolence—Imiquimod—skin cancer	0.0019	0.00192	CcSEcCtD
Naratriptan—Photosensitivity reaction—Fluorouracil—skin cancer	0.0019	0.00191	CcSEcCtD
Naratriptan—Alopecia—Bleomycin—skin cancer	0.00189	0.00191	CcSEcCtD
Naratriptan—Sinusitis—Temozolomide—skin cancer	0.00189	0.0019	CcSEcCtD
Naratriptan—Pneumonia—Fluorouracil—skin cancer	0.00187	0.00188	CcSEcCtD
Naratriptan—Erythema—Bleomycin—skin cancer	0.00187	0.00188	CcSEcCtD
Naratriptan—Hypersensitivity—Vemurafenib—skin cancer	0.00185	0.00187	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Imiquimod—skin cancer	0.00185	0.00186	CcSEcCtD
Naratriptan—Fatigue—Imiquimod—skin cancer	0.00185	0.00186	CcSEcCtD
Naratriptan—Atrial fibrillation—Docetaxel—skin cancer	0.00183	0.00185	CcSEcCtD
Naratriptan—Pain—Imiquimod—skin cancer	0.00183	0.00185	CcSEcCtD
Naratriptan—Acute coronary syndrome—Fluorouracil—skin cancer	0.00183	0.00184	CcSEcCtD
Naratriptan—Myocardial infarction—Fluorouracil—skin cancer	0.00182	0.00183	CcSEcCtD
Naratriptan—Neuropathy peripheral—Fluorouracil—skin cancer	0.00182	0.00183	CcSEcCtD
Naratriptan—Haemoglobin—Temozolomide—skin cancer	0.00182	0.00183	CcSEcCtD
Naratriptan—Haemorrhage—Temozolomide—skin cancer	0.00181	0.00182	CcSEcCtD
Naratriptan—Asthenia—Vemurafenib—skin cancer	0.0018	0.00182	CcSEcCtD
Naratriptan—Hallucination—Temozolomide—skin cancer	0.0018	0.00181	CcSEcCtD
Naratriptan—Hypoaesthesia—Temozolomide—skin cancer	0.0018	0.00181	CcSEcCtD
Naratriptan—Chills—Dactinomycin—skin cancer	0.00179	0.00181	CcSEcCtD
Naratriptan—Pruritus—Vemurafenib—skin cancer	0.00178	0.00179	CcSEcCtD
Naratriptan—Alopecia—Dactinomycin—skin cancer	0.00177	0.00178	CcSEcCtD
Naratriptan—Feeling abnormal—Imiquimod—skin cancer	0.00177	0.00178	CcSEcCtD
Naratriptan—Sinusitis—Fluorouracil—skin cancer	0.00174	0.00175	CcSEcCtD
Naratriptan—Erythema—Dactinomycin—skin cancer	0.00174	0.00175	CcSEcCtD
Naratriptan—Ill-defined disorder—Bleomycin—skin cancer	0.00173	0.00174	CcSEcCtD
Naratriptan—Anaemia—Bleomycin—skin cancer	0.00172	0.00174	CcSEcCtD
Naratriptan—Diarrhoea—Vemurafenib—skin cancer	0.00172	0.00173	CcSEcCtD
Naratriptan—Migraine—Docetaxel—skin cancer	0.00171	0.00172	CcSEcCtD
Naratriptan—Urticaria—Imiquimod—skin cancer	0.0017	0.00172	CcSEcCtD
Naratriptan—Body temperature increased—Imiquimod—skin cancer	0.00169	0.00171	CcSEcCtD
Naratriptan—Tinnitus—Temozolomide—skin cancer	0.00169	0.0017	CcSEcCtD
Naratriptan—Malaise—Bleomycin—skin cancer	0.00168	0.0017	CcSEcCtD
Naratriptan—Cardiac disorder—Temozolomide—skin cancer	0.00168	0.00169	CcSEcCtD
Naratriptan—Haemoglobin—Fluorouracil—skin cancer	0.00167	0.00169	CcSEcCtD
Naratriptan—Haemorrhage—Fluorouracil—skin cancer	0.00167	0.00168	CcSEcCtD
Naratriptan—Dizziness—Vemurafenib—skin cancer	0.00166	0.00167	CcSEcCtD
Naratriptan—Hypoaesthesia—Fluorouracil—skin cancer	0.00166	0.00167	CcSEcCtD
Naratriptan—Angiopathy—Temozolomide—skin cancer	0.00164	0.00165	CcSEcCtD
Naratriptan—Immune system disorder—Temozolomide—skin cancer	0.00163	0.00165	CcSEcCtD
Naratriptan—Cough—Bleomycin—skin cancer	0.00163	0.00164	CcSEcCtD
Naratriptan—Chills—Temozolomide—skin cancer	0.00162	0.00163	CcSEcCtD
Naratriptan—Dehydration—Docetaxel—skin cancer	0.00162	0.00163	CcSEcCtD
Naratriptan—Ill-defined disorder—Dactinomycin—skin cancer	0.00161	0.00163	CcSEcCtD
Naratriptan—Anaemia—Dactinomycin—skin cancer	0.00161	0.00162	CcSEcCtD
Naratriptan—Liver function test abnormal—Docetaxel—skin cancer	0.0016	0.00162	CcSEcCtD
Naratriptan—Vomiting—Vemurafenib—skin cancer	0.0016	0.00161	CcSEcCtD
Naratriptan—Alopecia—Temozolomide—skin cancer	0.0016	0.00161	CcSEcCtD
Naratriptan—Dry skin—Docetaxel—skin cancer	0.00159	0.0016	CcSEcCtD
Naratriptan—Myalgia—Bleomycin—skin cancer	0.00159	0.0016	CcSEcCtD
Naratriptan—Rash—Vemurafenib—skin cancer	0.00158	0.0016	CcSEcCtD
Naratriptan—Dermatitis—Vemurafenib—skin cancer	0.00158	0.00159	CcSEcCtD
Naratriptan—Hypersensitivity—Imiquimod—skin cancer	0.00158	0.00159	CcSEcCtD
Naratriptan—Headache—Vemurafenib—skin cancer	0.00157	0.00159	CcSEcCtD
Naratriptan—Erythema—Temozolomide—skin cancer	0.00157	0.00159	CcSEcCtD
Naratriptan—Discomfort—Bleomycin—skin cancer	0.00157	0.00158	CcSEcCtD
Naratriptan—Malaise—Dactinomycin—skin cancer	0.00157	0.00158	CcSEcCtD
Naratriptan—Cramp muscle—Docetaxel—skin cancer	0.00156	0.00158	CcSEcCtD
Naratriptan—Asthenia—Imiquimod—skin cancer	0.00154	0.00155	CcSEcCtD
Naratriptan—Confusional state—Bleomycin—skin cancer	0.00153	0.00155	CcSEcCtD
Naratriptan—Anaphylactic shock—Bleomycin—skin cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Oedema—Bleomycin—skin cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Pruritus—Imiquimod—skin cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Infection—Bleomycin—skin cancer	0.00151	0.00152	CcSEcCtD
Naratriptan—Nausea—Vemurafenib—skin cancer	0.00149	0.0015	CcSEcCtD
Naratriptan—Thrombocytopenia—Bleomycin—skin cancer	0.00149	0.0015	CcSEcCtD
Naratriptan—Arrhythmia—Fluorouracil—skin cancer	0.00149	0.0015	CcSEcCtD
Naratriptan—Vision blurred—Temozolomide—skin cancer	0.00148	0.00149	CcSEcCtD
Naratriptan—Myalgia—Dactinomycin—skin cancer	0.00148	0.00149	CcSEcCtD
Naratriptan—Tremor—Temozolomide—skin cancer	0.00147	0.00149	CcSEcCtD
Naratriptan—Alopecia—Fluorouracil—skin cancer	0.00147	0.00148	CcSEcCtD
Naratriptan—Diarrhoea—Imiquimod—skin cancer	0.00147	0.00148	CcSEcCtD
Naratriptan—Discomfort—Dactinomycin—skin cancer	0.00146	0.00147	CcSEcCtD
Naratriptan—Angina pectoris—Docetaxel—skin cancer	0.00146	0.00147	CcSEcCtD
Naratriptan—Ill-defined disorder—Temozolomide—skin cancer	0.00146	0.00147	CcSEcCtD
Naratriptan—Anaemia—Temozolomide—skin cancer	0.00145	0.00147	CcSEcCtD
Naratriptan—Erythema—Fluorouracil—skin cancer	0.00145	0.00146	CcSEcCtD
Naratriptan—Agitation—Temozolomide—skin cancer	0.00145	0.00146	CcSEcCtD
Naratriptan—Hypotension—Bleomycin—skin cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Oedema—Dactinomycin—skin cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Malaise—Temozolomide—skin cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Dizziness—Imiquimod—skin cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Vertigo—Temozolomide—skin cancer	0.00141	0.00142	CcSEcCtD
Naratriptan—Infection—Dactinomycin—skin cancer	0.00141	0.00142	CcSEcCtD
Naratriptan—Palpitations—Temozolomide—skin cancer	0.00139	0.0014	CcSEcCtD
Naratriptan—Thrombocytopenia—Dactinomycin—skin cancer	0.00139	0.0014	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00139	0.0014	CcSEcCtD
Naratriptan—Cough—Temozolomide—skin cancer	0.00137	0.00138	CcSEcCtD
Naratriptan—Paraesthesia—Bleomycin—skin cancer	0.00137	0.00138	CcSEcCtD
Naratriptan—Vision blurred—Fluorouracil—skin cancer	0.00137	0.00138	CcSEcCtD
Naratriptan—Convulsion—Temozolomide—skin cancer	0.00136	0.00137	CcSEcCtD
Naratriptan—Vomiting—Imiquimod—skin cancer	0.00136	0.00137	CcSEcCtD
Naratriptan—Dyspnoea—Bleomycin—skin cancer	0.00136	0.00137	CcSEcCtD
Naratriptan—Rash—Imiquimod—skin cancer	0.00135	0.00136	CcSEcCtD
Naratriptan—Dermatitis—Imiquimod—skin cancer	0.00135	0.00136	CcSEcCtD
Naratriptan—Pneumonia—Docetaxel—skin cancer	0.00135	0.00136	CcSEcCtD
Naratriptan—Headache—Imiquimod—skin cancer	0.00134	0.00135	CcSEcCtD
Naratriptan—Anaemia—Fluorouracil—skin cancer	0.00134	0.00135	CcSEcCtD
Naratriptan—Myalgia—Temozolomide—skin cancer	0.00134	0.00135	CcSEcCtD
Naratriptan—Arthralgia—Temozolomide—skin cancer	0.00134	0.00135	CcSEcCtD
Naratriptan—Anxiety—Temozolomide—skin cancer	0.00133	0.00135	CcSEcCtD
Naratriptan—Discomfort—Temozolomide—skin cancer	0.00132	0.00133	CcSEcCtD
Naratriptan—Acute coronary syndrome—Docetaxel—skin cancer	0.00132	0.00133	CcSEcCtD
Naratriptan—Myocardial infarction—Docetaxel—skin cancer	0.00131	0.00132	CcSEcCtD
Naratriptan—Neuropathy peripheral—Docetaxel—skin cancer	0.00131	0.00132	CcSEcCtD
Naratriptan—Dry mouth—Temozolomide—skin cancer	0.00131	0.00132	CcSEcCtD
Naratriptan—Pain—Bleomycin—skin cancer	0.0013	0.00131	CcSEcCtD
Naratriptan—Confusional state—Temozolomide—skin cancer	0.00129	0.0013	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00129	0.0013	CcSEcCtD
Naratriptan—Anaphylactic shock—Temozolomide—skin cancer	0.00128	0.00129	CcSEcCtD
Naratriptan—Oedema—Temozolomide—skin cancer	0.00128	0.00129	CcSEcCtD
Naratriptan—Infection—Temozolomide—skin cancer	0.00128	0.00129	CcSEcCtD
Naratriptan—Nausea—Imiquimod—skin cancer	0.00127	0.00128	CcSEcCtD
Naratriptan—Nervous system disorder—Temozolomide—skin cancer	0.00126	0.00127	CcSEcCtD
Naratriptan—Thrombocytopenia—Temozolomide—skin cancer	0.00126	0.00127	CcSEcCtD
Naratriptan—Convulsion—Fluorouracil—skin cancer	0.00126	0.00127	CcSEcCtD
Naratriptan—Feeling abnormal—Bleomycin—skin cancer	0.00125	0.00126	CcSEcCtD
Naratriptan—Skin disorder—Temozolomide—skin cancer	0.00125	0.00126	CcSEcCtD
Naratriptan—Hyperhidrosis—Temozolomide—skin cancer	0.00124	0.00125	CcSEcCtD
Naratriptan—Myalgia—Fluorouracil—skin cancer	0.00123	0.00124	CcSEcCtD
Naratriptan—Fatigue—Dactinomycin—skin cancer	0.00122	0.00123	CcSEcCtD
Naratriptan—Discomfort—Fluorouracil—skin cancer	0.00122	0.00123	CcSEcCtD
Naratriptan—Pain—Dactinomycin—skin cancer	0.00121	0.00122	CcSEcCtD
Naratriptan—Urticaria—Bleomycin—skin cancer	0.00121	0.00122	CcSEcCtD
Naratriptan—Haemoglobin—Docetaxel—skin cancer	0.00121	0.00122	CcSEcCtD
Naratriptan—Body temperature increased—Bleomycin—skin cancer	0.0012	0.00121	CcSEcCtD
Naratriptan—Haemorrhage—Docetaxel—skin cancer	0.0012	0.00121	CcSEcCtD
Naratriptan—Hypoaesthesia—Docetaxel—skin cancer	0.0012	0.00121	CcSEcCtD
Naratriptan—Confusional state—Fluorouracil—skin cancer	0.00119	0.0012	CcSEcCtD
Naratriptan—Anaphylactic shock—Fluorouracil—skin cancer	0.00118	0.00119	CcSEcCtD
Naratriptan—Oedema—Fluorouracil—skin cancer	0.00118	0.00119	CcSEcCtD
Naratriptan—Infection—Fluorouracil—skin cancer	0.00118	0.00118	CcSEcCtD
Naratriptan—Feeling abnormal—Dactinomycin—skin cancer	0.00117	0.00118	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00117	0.00118	CcSEcCtD
Naratriptan—Nervous system disorder—Fluorouracil—skin cancer	0.00116	0.00117	CcSEcCtD
Naratriptan—Thrombocytopenia—Fluorouracil—skin cancer	0.00116	0.00117	CcSEcCtD
Naratriptan—Paraesthesia—Temozolomide—skin cancer	0.00115	0.00116	CcSEcCtD
Naratriptan—Dyspnoea—Temozolomide—skin cancer	0.00114	0.00115	CcSEcCtD
Naratriptan—Somnolence—Temozolomide—skin cancer	0.00114	0.00115	CcSEcCtD
Naratriptan—Body temperature increased—Dactinomycin—skin cancer	0.00112	0.00113	CcSEcCtD
Naratriptan—Hypersensitivity—Bleomycin—skin cancer	0.00112	0.00113	CcSEcCtD
Naratriptan—Cardiac disorder—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Temozolomide—skin cancer	0.00111	0.00112	CcSEcCtD
Naratriptan—Fatigue—Temozolomide—skin cancer	0.00111	0.00112	CcSEcCtD
Naratriptan—Hypotension—Fluorouracil—skin cancer	0.00111	0.00111	CcSEcCtD
Naratriptan—Pain—Temozolomide—skin cancer	0.0011	0.00111	CcSEcCtD
Naratriptan—Constipation—Temozolomide—skin cancer	0.0011	0.00111	CcSEcCtD
Naratriptan—Asthenia—Bleomycin—skin cancer	0.00109	0.0011	CcSEcCtD
Naratriptan—Angiopathy—Docetaxel—skin cancer	0.00109	0.0011	CcSEcCtD
Naratriptan—Immune system disorder—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Naratriptan—Chills—Docetaxel—skin cancer	0.00108	0.00109	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00108	0.00109	CcSEcCtD
Naratriptan—Pruritus—Bleomycin—skin cancer	0.00108	0.00109	CcSEcCtD
Naratriptan—Arrhythmia—Docetaxel—skin cancer	0.00107	0.00108	CcSEcCtD
Naratriptan—Paraesthesia—Fluorouracil—skin cancer	0.00106	0.00107	CcSEcCtD
Naratriptan—Alopecia—Docetaxel—skin cancer	0.00106	0.00107	CcSEcCtD
Naratriptan—Feeling abnormal—Temozolomide—skin cancer	0.00106	0.00107	CcSEcCtD
Naratriptan—Dyspnoea—Fluorouracil—skin cancer	0.00105	0.00106	CcSEcCtD
Naratriptan—Somnolence—Fluorouracil—skin cancer	0.00105	0.00106	CcSEcCtD
Naratriptan—Erythema—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Naratriptan—Hypersensitivity—Dactinomycin—skin cancer	0.00105	0.00105	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00102	0.00103	CcSEcCtD
Naratriptan—Urticaria—Temozolomide—skin cancer	0.00102	0.00103	CcSEcCtD
Naratriptan—Asthenia—Dactinomycin—skin cancer	0.00102	0.00103	CcSEcCtD
Naratriptan—Body temperature increased—Temozolomide—skin cancer	0.00102	0.00102	CcSEcCtD
Naratriptan—Pain—Fluorouracil—skin cancer	0.00101	0.00102	CcSEcCtD
Naratriptan—Muscle spasms—Docetaxel—skin cancer	0.00101	0.00101	CcSEcCtD
Naratriptan—Feeling abnormal—Fluorouracil—skin cancer	0.000975	0.000982	CcSEcCtD
Naratriptan—Diarrhoea—Dactinomycin—skin cancer	0.000971	0.000979	CcSEcCtD
Naratriptan—Vomiting—Bleomycin—skin cancer	0.000968	0.000975	CcSEcCtD
Naratriptan—Anaemia—Docetaxel—skin cancer	0.000967	0.000975	CcSEcCtD
Naratriptan—Rash—Bleomycin—skin cancer	0.00096	0.000967	CcSEcCtD
Naratriptan—Dermatitis—Bleomycin—skin cancer	0.000959	0.000966	CcSEcCtD
Naratriptan—HTR1B—blood vessel—skin cancer	0.000954	0.124	CbGeAlD
Naratriptan—Hypersensitivity—Temozolomide—skin cancer	0.000946	0.000953	CcSEcCtD
Naratriptan—Urticaria—Fluorouracil—skin cancer	0.00094	0.000947	CcSEcCtD
Naratriptan—Syncope—Docetaxel—skin cancer	0.000938	0.000946	CcSEcCtD
Naratriptan—Body temperature increased—Fluorouracil—skin cancer	0.000935	0.000943	CcSEcCtD
Naratriptan—Palpitations—Docetaxel—skin cancer	0.000925	0.000932	CcSEcCtD
Naratriptan—HTR1D—blood vessel—skin cancer	0.000923	0.12	CbGeAlD
Naratriptan—Asthenia—Temozolomide—skin cancer	0.000921	0.000928	CcSEcCtD
Naratriptan—Loss of consciousness—Docetaxel—skin cancer	0.00092	0.000927	CcSEcCtD
Naratriptan—Cough—Docetaxel—skin cancer	0.000913	0.00092	CcSEcCtD
Naratriptan—Pruritus—Temozolomide—skin cancer	0.000908	0.000915	CcSEcCtD
Naratriptan—Convulsion—Docetaxel—skin cancer	0.000907	0.000914	CcSEcCtD
Naratriptan—Nausea—Bleomycin—skin cancer	0.000904	0.000911	CcSEcCtD
Naratriptan—Vomiting—Dactinomycin—skin cancer	0.000903	0.00091	CcSEcCtD
Naratriptan—MAOA—nerve—skin cancer	0.000895	0.116	CbGeAlD
Naratriptan—Rash—Dactinomycin—skin cancer	0.000895	0.000902	CcSEcCtD
Naratriptan—Myalgia—Docetaxel—skin cancer	0.000891	0.000898	CcSEcCtD
Naratriptan—Arthralgia—Docetaxel—skin cancer	0.000891	0.000898	CcSEcCtD
Naratriptan—Diarrhoea—Temozolomide—skin cancer	0.000879	0.000885	CcSEcCtD
Naratriptan—Hypersensitivity—Fluorouracil—skin cancer	0.000872	0.000878	CcSEcCtD
Naratriptan—Dry mouth—Docetaxel—skin cancer	0.000871	0.000878	CcSEcCtD
Naratriptan—Confusional state—Docetaxel—skin cancer	0.000861	0.000868	CcSEcCtD
Naratriptan—Anaphylactic shock—Docetaxel—skin cancer	0.000854	0.000861	CcSEcCtD
Naratriptan—Oedema—Docetaxel—skin cancer	0.000854	0.000861	CcSEcCtD
Naratriptan—Dizziness—Temozolomide—skin cancer	0.000849	0.000856	CcSEcCtD
Naratriptan—Infection—Docetaxel—skin cancer	0.000848	0.000855	CcSEcCtD
Naratriptan—Nausea—Dactinomycin—skin cancer	0.000843	0.00085	CcSEcCtD
Naratriptan—Shock—Docetaxel—skin cancer	0.00084	0.000847	CcSEcCtD
Naratriptan—Nervous system disorder—Docetaxel—skin cancer	0.000837	0.000844	CcSEcCtD
Naratriptan—Pruritus—Fluorouracil—skin cancer	0.000837	0.000844	CcSEcCtD
Naratriptan—Thrombocytopenia—Docetaxel—skin cancer	0.000836	0.000843	CcSEcCtD
Naratriptan—Skin disorder—Docetaxel—skin cancer	0.000829	0.000836	CcSEcCtD
Naratriptan—Vomiting—Temozolomide—skin cancer	0.000816	0.000823	CcSEcCtD
Naratriptan—Rash—Temozolomide—skin cancer	0.00081	0.000816	CcSEcCtD
Naratriptan—Diarrhoea—Fluorouracil—skin cancer	0.000809	0.000816	CcSEcCtD
Naratriptan—Dermatitis—Temozolomide—skin cancer	0.000809	0.000815	CcSEcCtD
Naratriptan—Headache—Temozolomide—skin cancer	0.000804	0.000811	CcSEcCtD
Naratriptan—Hypotension—Docetaxel—skin cancer	0.000798	0.000804	CcSEcCtD
Naratriptan—Dizziness—Fluorouracil—skin cancer	0.000782	0.000788	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000778	0.000784	CcSEcCtD
Naratriptan—Paraesthesia—Docetaxel—skin cancer	0.000767	0.000773	CcSEcCtD
Naratriptan—Nausea—Temozolomide—skin cancer	0.000763	0.000769	CcSEcCtD
Naratriptan—Dyspnoea—Docetaxel—skin cancer	0.000761	0.000767	CcSEcCtD
Naratriptan—Somnolence—Docetaxel—skin cancer	0.000759	0.000765	CcSEcCtD
Naratriptan—Vomiting—Fluorouracil—skin cancer	0.000752	0.000758	CcSEcCtD
Naratriptan—Rash—Fluorouracil—skin cancer	0.000746	0.000752	CcSEcCtD
Naratriptan—Dermatitis—Fluorouracil—skin cancer	0.000745	0.000751	CcSEcCtD
Naratriptan—Headache—Fluorouracil—skin cancer	0.000741	0.000747	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Docetaxel—skin cancer	0.000737	0.000743	CcSEcCtD
Naratriptan—Fatigue—Docetaxel—skin cancer	0.000736	0.000742	CcSEcCtD
Naratriptan—Constipation—Docetaxel—skin cancer	0.00073	0.000736	CcSEcCtD
Naratriptan—Pain—Docetaxel—skin cancer	0.00073	0.000736	CcSEcCtD
Naratriptan—Feeling abnormal—Docetaxel—skin cancer	0.000704	0.000709	CcSEcCtD
Naratriptan—HTR1F—head—skin cancer	0.000703	0.0912	CbGeAlD
Naratriptan—Nausea—Fluorouracil—skin cancer	0.000703	0.000708	CcSEcCtD
Naratriptan—Body temperature increased—Docetaxel—skin cancer	0.000675	0.00068	CcSEcCtD
Naratriptan—Hypersensitivity—Docetaxel—skin cancer	0.000629	0.000634	CcSEcCtD
Naratriptan—Asthenia—Docetaxel—skin cancer	0.000613	0.000617	CcSEcCtD
Naratriptan—Pruritus—Docetaxel—skin cancer	0.000604	0.000609	CcSEcCtD
Naratriptan—Diarrhoea—Docetaxel—skin cancer	0.000584	0.000589	CcSEcCtD
Naratriptan—Dizziness—Docetaxel—skin cancer	0.000565	0.000569	CcSEcCtD
Naratriptan—Vomiting—Docetaxel—skin cancer	0.000543	0.000547	CcSEcCtD
Naratriptan—Rash—Docetaxel—skin cancer	0.000538	0.000543	CcSEcCtD
Naratriptan—Dermatitis—Docetaxel—skin cancer	0.000538	0.000542	CcSEcCtD
Naratriptan—Headache—Docetaxel—skin cancer	0.000535	0.000539	CcSEcCtD
Naratriptan—MAOA—nipple—skin cancer	0.000508	0.0659	CbGeAlD
Naratriptan—Nausea—Docetaxel—skin cancer	0.000507	0.000511	CcSEcCtD
Naratriptan—MAOA—neck—skin cancer	0.000503	0.0652	CbGeAlD
Naratriptan—HTR1D—connective tissue—skin cancer	0.000473	0.0614	CbGeAlD
Naratriptan—MAOA—connective tissue—skin cancer	0.000361	0.0468	CbGeAlD
Naratriptan—HTR1B—female reproductive system—skin cancer	0.000345	0.0447	CbGeAlD
Naratriptan—HTR1D—female reproductive system—skin cancer	0.000334	0.0433	CbGeAlD
Naratriptan—MAOA—mammalian vulva—skin cancer	0.000297	0.0385	CbGeAlD
Naratriptan—HTR1B—head—skin cancer	0.000288	0.0374	CbGeAlD
Naratriptan—HTR1D—head—skin cancer	0.000279	0.0362	CbGeAlD
Naratriptan—MAOA—female reproductive system—skin cancer	0.000254	0.033	CbGeAlD
Naratriptan—HTR1A—head—skin cancer	0.000233	0.0302	CbGeAlD
Naratriptan—MAOA—head—skin cancer	0.000212	0.0275	CbGeAlD
Naratriptan—MAOA—lymph node—skin cancer	0.000149	0.0193	CbGeAlD
